Obesity News

NEW ORLEANS — Nearly all participants with obesity without diabetes assigned tirzepatide experienced at least 5% weight loss over 72 weeks compared with placebo, with at least 20% weight loss in more than half with the highest 15 mg dose.

The FDA will reevaluate the safety of bisphenol A in food packaging, according to a press release from the Environmental Defense Fund.

When treating a patient with multiple diagnoses, it can be difficult to know which to address first.

Nationwide, there is significantly increased interest and focus on addressing racial and ethnic health disparities.

Myths can be major barriers for people with obesity to access treatment, and educating patients to overcome them is critical.

Patient-centered strategies and a teamwork approach with registered dieticians may benefit the creation of tailored dietary interventions for treating obesity, said a speaker at the Obesity Medicine Association Spring Conference.

Intermittent fasting can provide flexibility, convenience, affordability and simplicity to any diet if implemented correctly, according to a presentation at the Obesity Medicine Association Spring Conference.

Interventions based on regulation of cues with or without behavioral weight loss could serve as alternative weight loss approaches for adults who struggle with food responsiveness, according to findings published in JAMA Network Open.

The term “weight loss” is everywhere these days.

Adults with obesity who lost weight while dieting struggled to maintain their weight loss if they slept less than 6 hours per night, according to findings presented at the European Congress on Obesity.